Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 272 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 946. Clear
Clear
Q2
UCB, INC. for UCB, INC.
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code, Tariff (miscellaneous tariff bills)
View →
2A
PUBLIC CITIZEN for PUBLIC CITIZEN
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Taxation/Internal Revenue Code, Banking, Budget/Appropriations, Civil Rights/Civil Liberties
View →
Q2
DLA PIPER LLP (US) for BIOTECHNOLOGY INNOVATION ORGANIZATION
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medical/Disease Research/Clinical Labs, Health Issues, Medicare/Medicaid, Pharmacy
View →
Q2
PUBLIC CITIZEN for PUBLIC CITIZEN
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Banking, Budget/Appropriations, Civil Rights/Civil Liberties, Consumer Issues/Safety/Products
View →
Q2
INCYTE CORPORATION for INCYTE CORPORATION
2nd Quarter (Apr 1 - June 30) 2025 · Delaware · House · Senate
Medicare/Medicaid
View →
Q2
COVINGTON & BURLING LLP for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · Senate · $220,000.00 income
Copyright/Patent/Trademark, Health Issues
View →
Q2
ACADIA PHARMACEUTICALS for ACADIA PHARMACEUTICALS
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate
Taxation/Internal Revenue Code, Health Issues, Medicare/Medicaid
View →
Q2
PTC THERAPEUTICS, INC. for PTC THERAPEUTICS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate
Taxation/Internal Revenue Code, Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q2
TAKEDA PHARMACEUTICALS AMERICA, INC. for TAKEDA PHARMACEUTICALS AMERICA INC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code
View →
Q2
JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate
Health Issues, Budget/Appropriations, Copyright/Patent/Trademark, Law Enforcement/Crime/Criminal Justice
View →
Q2
HARMONY BIOSCIENCES for HARMONY BIOSCIENCES
2nd Quarter (Apr 1 - June 30) 2025 · Pennsylvania · House · Senate
Pharmacy
View →
Q2
NOVARTIS for NOVARTIS
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q2
AARP for AARP
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Health Issues, Pharmacy, Family issues/Abortion/Adoption
View →
Q2
MARSHALL & POPP, LLC for JAZZ PHARMACEUTICALS, INC. AND ITS SUBSIDIARIES, INCLUDING GREENWICH BIOSCIENCES
2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $40,000.00 income
Budget/Appropriations, Health Issues
View →
Q2
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View →
Q2
DAIICHI SANKYO, INC. for DAIICHI SANKYO INC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Taxation/Internal Revenue Code
View →
Q2
TIBER CREEK GROUP for DAIICHI SANKYO, INC.
2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate · $50,000.00 income
Health Issues
View →
Q2
TIBER CREEK GROUP for BEONE MEDICINES USA, INC. (FKA BEIGENE USA, INC.)
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $70,000.00 income
Health Issues, Medicare/Medicaid
View →
Q2
TIBER CREEK GROUP for ASTELLAS PHARMA US, INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View →
Q2
TIBER CREEK GROUP for INCYTE CORPORATION
2nd Quarter (Apr 1 - June 30) 2025 · Delaware · House · Senate · $80,000.00 income
Medicare/Medicaid
View →
Q2
TIBER CREEK GROUP for EMD SERONO, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $50,000.00 income
Health Issues, Medicare/Medicaid
View →
Q2
TIBER CREEK GROUP for ASTRAZENECA
2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $90,000.00 income
Medicare/Medicaid
View →
Q2
TIBER CREEK GROUP for ALNYLAM PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid
View →
Q2
TODD STRATEGY GROUP for ALNYLAM PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid
View →
Q2
TODD STRATEGY GROUP for ALEXION PHARMACEUTICALS, INC.
2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $80,000.00 income
Medicare/Medicaid, Health Issues
View →
Previous Page 8 of 11 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem